RNS Number : 7992M
MaxCyte, Inc.
19 November 2024
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i


1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

MAXCYTE INC

1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

 X

An acquisition or disposal of financial instruments


An event changing the breakdown of voting rights


Other (please specify) iii:


3. Details of person subject to the notification obligation iv

Name

BlackRock, Inc.

City and country of registered office (if applicable)

Wilmington, DE, USA

4. Full name of shareholder(s) (if different from 3.) v

Name


City and country of registered office (if applicable)


5. Date on which the threshold was crossed or reached vi:

14/11/2024

6. Date on which issuer notified (DD/MM/YYYY):

15/11/2024

7. Total positions of person(s) subject to the notification obligation


% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

8.88%

0.49%

9.37%

9,893,368

Position of previous notification (if

applicable)

9.00%

0.73%

9.74%


 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type of
shares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

US57777K1060


9,374,946


8.88%











SUBTOTAL 8. A

9,374,946

8.88%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expiration
date x

Exercise/
Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

Securities Lending

N/A

N/A

518,422

0.49%













SUBTOTAL 8. B 1

518,422

0.49%

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expiration
date x

Exercise/
Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights





















 

SUBTOTAL 8.B.2



 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii


Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold





BlackRock, Inc.




BlackRock Finance, Inc.




Trident Merger, LLC




BlackRock Investment Management, LLC








BlackRock, Inc.




BlackRock Finance, Inc.




BlackRock Holdco 2, Inc.




BlackRock Financial Management, Inc.




BlackRock International Holdings, Inc.




BR Jersey International Holdings L.P.




BlackRock Holdco 3, LLC




BlackRock Cayman 1 LP




BlackRock Cayman West Bay Finco Limited




BlackRock Cayman West Bay IV Limited




BlackRock Group Limited




BlackRock Finance Europe Limited




BlackRock Investment Management (UK) Limited








BlackRock, Inc.




BlackRock Finance, Inc.




BlackRock Holdco 2, Inc.




BlackRock Financial Management, Inc.




BlackRock Holdco 4, LLC




BlackRock Holdco 6, LLC




BlackRock Delaware Holdings Inc.




BlackRock Institutional Trust Company, National Association








BlackRock, Inc.




BlackRock Finance, Inc.




BlackRock Holdco 2, Inc.




BlackRock Financial Management, Inc.




BlackRock Holdco 4, LLC




BlackRock Holdco 6, LLC




BlackRock Delaware Holdings Inc.




BlackRock Fund Advisors

4.51%

0.30%

4.82%





BlackRock, Inc.




BlackRock Finance, Inc.




BlackRock Holdco 2, Inc.




BlackRock Financial Management, Inc.








BlackRock, Inc.




BlackRock Finance, Inc.




BlackRock Holdco 2, Inc.




BlackRock Financial Management, Inc.




BlackRock International Holdings, Inc.




BlackRock Canada Holdings ULC




BlackRock Asset Management Canada Limited








BlackRock, Inc.




BlackRock Finance, Inc.




BlackRock Holdco 2, Inc.




BlackRock Financial Management, Inc.




BlackRock Capital Holdings, Inc.




BlackRock Advisors, LLC








BlackRock, Inc.




BlackRock Finance, Inc.




BlackRock Holdco 2, Inc.




BlackRock Financial Management, Inc.




BlackRock International Holdings, Inc.




BR Jersey International Holdings L.P.




BlackRock Holdco 3, LLC




BlackRock Cayman 1 LP




BlackRock Cayman West Bay Finco Limited




BlackRock Cayman West Bay IV Limited




BlackRock Group Limited




BlackRock Finance Europe Limited




BlackRock Advisors (UK) Limited








BlackRock, Inc.




BlackRock Finance, Inc.




Trident Merger, LLC




BlackRock Investment Management, LLC




Amethyst Intermediate, LLC




Aperio Holdings, LLC




Aperio Group, LLC








 

10. In case of proxy voting, please identify:

Name of the proxy holder


The number and % of voting rights held


The date until which the voting rights will be held



11. Additional information xvi

 

BlackRock Regulatory Threshold Reporting Team
 
Jana Blumenstein

020 7743 3650

 

 

Place of completion

12 Throgmorton Avenue, London, EC2N 2DL, U.K.

Date of completion

15 November 2024

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFIFSALELALIS
Maxcyte (LSE:MXCT)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Maxcyte Charts.
Maxcyte (LSE:MXCT)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Maxcyte Charts.